GlassScriptPhysician profile
Jorge J Zequeira
NPI 1205030988
$1,885.31
in general payments reported to CMS, 2019-2025
11 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Pediatric Surgery provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2021: $268 · 2022: $390 · 2023: $351 · 2024: $20.00 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $458.19 | 2021-2023 | 1788 |
| Merck Sharp & Dohme LLC | $307.70 | 2019-2024 | Keytruda, Gardasil 9, Vaqta |
| Boston Scientific Corporation | $244.09 | 2021-2023 | |
| Johnson and Johnson International | $169.96 | 2019-2023 | Echelon Flex, Enseal X1 |
| Biom'Up Sa | $124.92 | 2019 | |
| Olympus Latin America, INC. | $121.46 | 2025 | Olympus |
| Takeda Pharmaceuticals U.S.A., INC. | $118.71 | 2022 | |
| Glaxosmithkline, LLC. | $100.00 | 2019 | |
| Allergan, INC. | $93.83 | 2019 | |
| Medtronic, INC. | $81.20 | 2019-2025 | Sonicision, Premium Surgiclip III |
| Zimmer Biomet Holdings, INC. | $65.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Zequeira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.